UNITED STATES SECURITIES AND EXCHANGE COMMISSION As filed with the Securities and Exchange Commission on October 8, 2024 Registration Statement No. 333- (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Spiro Rombotis President & Chief Executive Officer Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 (908) 517-7330 WASHINGTON, DC 20549 FORM S-1 REGISTRATION STATEMENT under the SECURITIES ACT OF 1933 C ...

As filed with the Securities and Exchange Commission on May 6, 2024 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-1 REGISTRATION STATEMENT under the SECURITIES ACT OF 1933 CYCLACEL PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Delaware 3826 91-1707622 (Primary Standard Industrial Classification Code Number) 200 Connell Drive, Suite 1500 Berkeley Heights ...

As filed with the Securities and Exchange Commission on April 19, 2024 Registration Statement No. 333-278197 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT under the SECURITIES ACT OF 1933 CYCLACEL PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) (IRS Employer Identification No.) (State or other jurisdiction of incorporation or organization) Delaware 3826 91-1707622 (Primary Standard Industrial Classificati ...

As filed with the Securities and Exchange Commission on January 19, 2024 Registration Statement No. 333- (State or other jurisdiction of incorporation or organization) Delaware 3826 91-1707622 (Primary Standard Industrial Classification Code Number) (IRS Employer Identification No.) 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 (908) 517-7330 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-1 REGISTRATION STATEMENT under the SECURITIES ACT OF 1933 CYCLACEL PHARMACEUTIC ...

As filed with the Securities and Exchange Commission on January 19, 2024 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-1 REGISTRATION STATEMENT under the SECURITIES ACT OF 1933 CYCLACEL PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Delaware 3826 91-1707622 (Primary Standard Industrial Classification Code Number) (IRS Employer Identification No.) 200 Con ...